 Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL Q1 2022 Results Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Paul Friedman - Chairman and Chief Executive Officer Rebecca Taub - Founder, Chief Medical Officer and President of Research Development Remy Sukhija - Chief Commercial Officer Alex Howarth - Chief Financial Officer Stephen Harrison - M.D., Medical Director, Pinnacle Clinical Research Conference Call Participants Ritu Baral - Cowen Thomas Smith - SVB Securities Yasmeen Rahimi - Piper Sandler Andrea Tan - Goldman Sachs Liisa Bayko - Evercore ISI Operator Good day, ladies and gentlemen, and welcome to the Madrigal Pharmaceuticals First Quarter 2022 Conference Call. 